| Year |
Citation |
Score |
| 2017 |
Melville Z, Hernandez-Ochoa EO, Pratt SJ, Liu Y, Pierce AD, Wilder PT, Adipietro KA, Breysse DH, Varney K, Schneider MF, Weber DJ. The activation of PKA by the calcium-binding protein S100A1 is independent of cyclic AMP. Biochemistry. PMID 28409622 DOI: 10.1021/Acs.Biochem.7B00117 |
0.382 |
|
| 2017 |
Alasady MJ, Adipietro KA, Pierce AD, Wilder PT, Hartman KG, Weber DJ, Hay N. Abstract 315: S100B regulates IL-6 signaling via the p90 ribosomal S6 kinase (RSK) in malignant melanoma Cancer Research. 77: 315-315. DOI: 10.1158/1538-7445.Am2017-315 |
0.309 |
|
| 2016 |
Cavalier MC, Melville Z, Aligholizadeh E, Raman EP, Yu W, Fang L, Alasady M, Pierce AD, Wilder PT, MacKerell AD, Weber DJ. Novel protein-inhibitor interactions in site 3 of Ca(2+)-bound S100B as discovered by X-ray crystallography. Acta Crystallographica. Section D, Structural Biology. 72: 753-760. PMID 27303795 DOI: 10.1107/S2059798316005532 |
0.35 |
|
| 2015 |
Mochin MT, Underwood KF, Cooper B, McLenithan JC, Pierce AD, Nalvarte C, Arbiser J, Karlsson AI, Moise AR, Moskovitz J, Passaniti A. Hyperglycemia and redox status regulate RUNX2 DNA-binding and an angiogenic phenotype in endothelial cells. Microvascular Research. 97: 55-64. PMID 25283348 DOI: 10.1016/J.Mvr.2014.09.008 |
0.643 |
|
| 2015 |
Mochin MT, Underwood KF, Cooper B, McLenithan JC, Pierce AD, Nalvarte C, Arbiser J, Karlsson AI, Moise AR, Moskovitz J, Passaniti A. Hyperglycemia and redox status regulate RUNX2 DNA-binding and an angiogenic phenotype in endothelial cells Microvascular Research. 97: 55-64. DOI: 10.1016/j.mvr.2014.09.008 |
0.628 |
|
| 2014 |
Cavalier MC, Pierce AD, Wilder PT, Alasady MJ, Hartman KG, Neau DB, Foley TL, Jadhav A, Maloney DJ, Simeonov A, Toth EA, Weber DJ. Covalent small molecule inhibitors of Ca(2+)-bound S100B. Biochemistry. 53: 6628-40. PMID 25268459 DOI: 10.1021/Bi5005552 |
0.428 |
|
| 2014 |
Hartman KG, Vitolo MI, Pierce AD, Fox JM, Shapiro P, Martin SS, Wilder PT, Weber DJ. Complex formation between S100B protein and the p90 ribosomal S6 kinase (RSK) in malignant melanoma is calcium-dependent and inhibits extracellular signal-regulated kinase (ERK)-mediated phosphorylation of RSK. The Journal of Biological Chemistry. 289: 12886-95. PMID 24627490 DOI: 10.1074/Jbc.M114.561613 |
0.587 |
|
| 2014 |
Pierce AD. Abstract 4201: Activation of p90 ribosomal S6 kinase (RSK) and downstream targets are directly regulated by S100B protein in malignant melanoma Cancer Research. 74: 4201-4201. DOI: 10.1158/1538-7445.Am2014-4201 |
0.444 |
|
| 2013 |
Pierce AD, Hartman KG, Weber D. Abstract 5243: The novel calcium-dependent direct binding of S100B to p90 ribosomal S6 kinase (RSK) decreases MAP kinase-mediated RSK activation in malignant melanoma. Cancer Research. 73: 5243-5243. DOI: 10.1158/1538-7445.Am2013-5243 |
0.489 |
|
| 2012 |
Underwood KF, D'Souza DR, Mochin-Peters M, Pierce AD, Kommineni S, Choe M, Bennett J, Gnatt A, Habtemariam B, MacKerell AD, Passaniti A. Regulation of RUNX2 transcription factor-DNA interactions and cell proliferation by vitamin D3 (cholecalciferol) prohormone activity. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 27: 913-25. PMID 22189971 DOI: 10.1002/Jbmr.1504 |
0.619 |
|
| 2012 |
Pierce AD, Anglin IE, Vitolo MI, Mochin MT, Underwood KF, Goldblum SE, Kommineni S, Passaniti A. Glucose-activated RUNX2 phosphorylation promotes endothelial cell proliferation and an angiogenic phenotype. Journal of Cellular Biochemistry. 113: 282-92. PMID 21913213 DOI: 10.1002/Jcb.23354 |
0.635 |
|
| Show low-probability matches. |